NBIX- Neurocrine Biosciences, Inc.

Insider activity in NBIX over the last quarter tilts toward selling: insiders offloaded a net 6,541 shares worth roughly $1.1M.

Classified under Pharmaceuticals (Health Care sector), NBIX's insider flows are most useful compared with peers in the same group.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Gorman Kevin Charles	517.8K	$80.89M	-
CEO	Gano Kyle	154.7K	$24.17M	-
Other	Benevich Eric	67.3K	$10.51M	-
Other	Lippoldt Darin	56.8K	$8.87M	-
CFO	Abernethy Matt	42.8K	$6.73M	-

Buys and sells only

10 filings · page 13

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Feb 8, 2024	Boyer David W.51	Chief Corp. Affairs Officer	Sell	1,784	$137.09	$244,563.90	-26.7%	+3.4%	-8.8%
Feb 1, 2024	Delaet Ingrid66	Chief Regulatory Officer	Sell	1,045	$140.65	$146,975.39	-13.2%	+0.4%	+6.6%
Jan 31, 2024	Boyer David W.51	Chief Corp. Affairs Officer	Sell	2,096	$140.80	$295,115.14	-30.0%	-1.6%	+9.7%
Jan 31, 2024	Cooke Julie59	Chief Human Resources Officer	Sell	1,740	$141.29	$245,841.50	-9.2%	-1.6%	+9.7%
Jan 31, 2024	Abernethy Matt57	Chief Financial Officer	Sell	1,283	$140.72	$180,538.76	-4.3%	-1.6%	+9.7%
Jan 31, 2024	Benevich Eric62	Chief Commercial Officer	Sell	1,207	$140.78	$169,926.77	-3.1%	-1.6%	+9.7%
Jan 31, 2024	Gano Kyle54	Chief Business Development Off	Sell	1,541	$140.70	$216,812.54	-1.2%	-1.6%	+9.7%
Jan 31, 2024	Gorman Kevin Charles55	Chief Executive Officer	Sell	2,707	$140.69	$380,844.58	-0.5%	-1.6%	+9.7%
Jan 31, 2024	Lippoldt Darin60	Chief Legal Officer	Sell	1,250	$140.65	$175,809.75	-3.3%	-1.6%	+9.7%
Jan 31, 2024	Onyia Jude51	Chief Scientific Officer	Sell	126	$141.94	$17,884.44	-1.1%	-1.6%	+9.7%